Relay Therapeutics, Inc. - RLAY

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$4.64B
QoQ value delta ($000)
+$2.795B (+151.5%)
Implied price effect (QoQ)
+86.64%
Shares
Total shares
249,971,353
QoQ shares delta
+64,467,292 (+34.75%)
Total shares held by funds (by quarter)

Market chart (RLAY)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 262 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
SB INVESTMENT ADVISERS (UK) LTD 522,101 27,904,963 6.81%
FMR LLC 376,260 20,110,113 0.02%
Casdin Capital, LLC 300,019 16,035,240 15.02%
BlackRock, Inc. 286,042 15,288,202 0.0%
PERCEPTIVE ADVISORS LLC 263,926 14,106,187 3.96%
Commodore Capital LP 224,520 12,000,000 13.37%
STATE STREET CORP 189,474 10,125,381 0.01%
VANGUARD CAPITAL MANAGEMENT LLC 167,724 8,964,423 0.0%
PRICE T ROWE ASSOCIATES INC /MD/ 144,227 7,708,507 0.01%
Nextech Invest Ltd. 126,788 6,776,506 6.02%
Bellevue Group AG 115,739 6,185,970 2.44%
GEODE CAPITAL MANAGEMENT, LLC 88,448 4,726,576 0.0%
TCG Crossover Management, LLC 79,954 4,273,356 1.92%
MORGAN STANLEY 72,053 3,851,071 0.0%
Siren, L.L.C. 68,291 3,650,000 1.38%
GOLDMAN SACHS GROUP INC 63,776 3,408,701 0.01%
WESTFIELD CAPITAL MANAGEMENT CO LP 62,556 3,343,496 0.2%
Kynam Capital Management, LP 61,743 3,300,000 3.41%
DIMENSIONAL FUND ADVISORS LP 58,533 3,127,564 0.01%
Spruce Street Capital LP 55,832 2,984,125 10.95%
VANGUARD PORTFOLIO MANAGEMENT LLC 54,124 2,892,785 0.0%
BAKER BROS. ADVISORS LP 52,889 2,826,783 0.27%
BANK OF AMERICA CORP /DE/ 50,425 2,695,108 0.0%
MPM BioImpact LLC 45,197 2,415,672 2.76%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 41,890 2,238,929 0.02%